poisar

Stocks · News reference

Philip Morris International's U.S. Affiliate Swedish Match USA Receives FDA's Marketing Granted Orders To Advertise 11 ZYN ULTRA Moist Oral Nicotine Pouch Products

BenzingaBenzinga Newsdesk

Philip Morris International Inc. (NYSE:PM) today announces that the U.S. Food and Drug Administration (FDA) issued Marketing Granted Orders to PMI’s U.S. affiliate, Swedish Match USA, Inc., authorizing the marketing of

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. The Motley FoolMicah Zimmerman

    I've Been Wrong About Philip Morris International Stock for 5 Years. Here's Why I'm Finally Changing My Mind.

    The author reverses his 5-year bearish stance on Philip Morris International after the company successfully pivoted from declining cigarettes to higher-margin smoke-free products. Smoke-free products now represent 42% of revenue (up from 24% in 2020), with strong growth in IQOS heated tobacco and ZYN nicotine pouches. Q2 results beat expectations with 10.4% revenue growth and 15.2% EPS growth. However, at current valuations near $192, the stock is no longer considered cheap despite the improved business fundamentals.